Related Experiment Videos
Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using
X Jin1, C G Roberts, D F Nixon
1Aaron Diamond AIDS Research Center, Rockefeller University, New York, New York 10016, USA. xjin@adarc.org
AIDS Research and Human Retroviruses
|January 11, 2000
Summary
Standard methods may miss some cytotoxic T lymphocyte (CTL) responses to HIV-1. This study identified additional subdominant CTL epitopes using more sensitive assays, revealing a broader immune response in a long-term nonprogressor.
Area of Science:
- Immunology
- Virology
- Computational Biology
Background:
- Conventional cytotoxic T lymphocyte (CTL) assays for HIV-1 may underestimate epitope recognition.
- Reasons include use of lab-adapted strains, specific cell lines (EBV-transformed B-LCLs), and insensitive assays (PBMCs).
- This can obscure subdominant CTL responses and limit understanding of immune surveillance.
Purpose of the Study:
- To investigate the full breadth of CTL epitopes recognized in an HIV-1 long-term nonprogressor (LTNP).
- To identify subdominant CTL epitopes beyond the dominant, highly conserved ones.
- To develop and apply more sensitive methods for detecting low-level CTL responses.
Main Methods:
- Identified an immunodominant HLA-B7-restricted CTL epitope using standard cloning.
- Sequenced autologous HIV-1 proviral DNA and used the EpiMatrix algorithm to predict potential epitopes.
- Synthesized predicted peptides, tested HLA-B7 binding, and used autologous dendritic cells for sensitive CTL stimulation.
Main Results:
- Identified an immunodominant HLA-B7-restricted CTL epitope.
- EpiMatrix predicted 55 peptides with high likelihood of HLA-B7 binding; 10 showed binding.
- Using peptide-pulsed autologous dendritic cells, three additional subdominant CTL epitopes were discovered.
Conclusions:
- Conventional CTL assays may underestimate the breadth of HIV-1 epitope recognition.
- More sensitive methods, including computational prediction and autologous antigen-presenting cells, can reveal subdominant epitopes.
- A broader understanding of CTL responses is crucial for vaccine development and immune monitoring.